US Stock MarketDetailed Quotes

OLMA Olema Pharmaceuticals

Watchlist
  • 11.320
  • +0.120+1.07%
Close Mar 28 16:00 ET
  • 11.090
  • -0.230-2.03%
Post 19:29 ET
632.95MMarket Cap-5289P/E (TTM)

About Olema Pharmaceuticals Company

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of next generation targeted therapies for women’s cancers. Its product candidate, OP-1250, is a novel oral therapy with combined activity as both a complete ER antagonist, or CERAN, and a selective ER degrader, or SERD, which is believed to drive deeper, more durable responses than existing therapies. The company was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.

Company Profile

SymbolOLMA
Company NameOlema Pharmaceuticals
Listing Date11/19/2020
Issue Price19.00
Founded2006
CEODr. Sean Bohen, M.D.,PhD
MarketNASDAQ
Employees74
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address780 Brannan Street
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94103
Phone1-650-243-5555

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Sean Bohen, M.D.,PhD
  • Director, President and Chief Executive Officer
  • 5.99M
  • John B. Moriarty, J.D.
  • Executive Vice President, Chief Legal Officer and Corporate Secretary
  • 3.02M
  • Shane Kovacs
  • Principal Accounting Officer, Chief Operating and Financial Officer
  • 2.27M
  • Dr. David C. Myles, PhD
  • Chief Discovery and Non-Clinical Development Officer
  • --
  • Dr. Naseem Zojwalla
  • Chief Medical Officer
  • 2.25M
  • Ian T. Clark
  • Chairman of the Board
  • 134.94K
  • Scott Garland
  • Director
  • --
  • Dr. Cyrus L. Harmon, PhD
  • Director
  • 300.00K
  • Andrew S. Rappaport
  • Independent Director
  • 106.94K
  • Cynthia M. Butitta
  • Independent Director
  • 114.94K
  • Dr. Sandra J. Horning, M.D.
  • Independent Director
  • 92.94K
  • Dr. Graham Walmsley, M.D.,PhD
  • Independent Director
  • 105.94K
  • Yi Larson
  • Independent Director
  • 97.94K
  • Dr. Gorjan Hrustanovic, PhD
  • Independent Director
  • 102.94K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg